Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Thalidomide analogue CC-1069 shows potent antiarthritic activity in rat model

Nov. 20, 1998

Inhibitor of selectin-dependent cell adhesion (BMS-184000) evaluated in models of inflammation

Nov. 19, 1998

ACR attendants learn more about the efficacy and safety of Enbrel in patients with RA, JRA

Nov. 19, 1998

p38 kinase inhibitor RWJ-68354: a promising clinical candidate for inflammatory conditions

Nov. 19, 1998

Novel antibody with potential in treating RA investigated by Santen

Nov. 18, 1998

MMP inhibitor BMS-453 improves disease symptoms in mice with experimental arthritis

Nov. 18, 1998

SB pursues CCR5 antagonists for the treatment of inflammation

Nov. 18, 1998

New osteoarthritis treatment candidate blocks cartilage degradation

Nov. 18, 1998

MK-966 improves physical ability and quality of life in patients with OA, RA

Nov. 18, 1998

Amgen evaluates novel TNF-targeted immunotherapy in patients with active RA

Nov. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...